» Articles » PMID: 30630462

Long-term Results of Glaucoma Drainage Device Surgery

Overview
Journal BMC Ophthalmol
Publisher Biomed Central
Specialty Ophthalmology
Date 2019 Jan 12
PMID 30630462
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To evaluate long-term results of eyes with glaucoma drainage device (GDD).

Methods: We retrospectively reviewed medical records of all patients who underwent GDD placement at our institution between 2001 and 2014. A total of 110 eyes of 90 patients were studied. Glaucoma outcome was assessed by postoperative intraocular pressure (IOP), number of medications, and need for further glaucoma surgery. Surgical procedures before and during the study period, and their complications were evaluated.

Results: The mean follow-up was 78.3 ± 44.0 months. The mean preoperative intraocular pressure was 30.8 ± 6.9 mmHg with 3.5 ± 1.1 glaucoma medications. At last postoperative follow-up, the mean IOP decreased to 14.3 ± 5.4 mmHg with 1.6 ± 1.5 glaucoma medications. GDD implantation successfully controlled glaucoma in 86, 85, 81, 78, 79, 76 and 73% of eyes at 1, 2, 3, 4, 5, 7 and 10 years, respectively. At last follow-up IOP was successfully controlled in 67% of eyes. Clinical complications occurred in 56.4% of eyes during the follow-up period.

Conclusions: A glaucoma drainage device can successfully control intractable glaucoma even after a very long period of time.

Citing Articles

Short-Term Outcomes of Trabeculectomy With or Without Anti-VEGF in Patients With Neovascular Glaucoma: A Systematic Review and Meta-Analysis.

Zhou X, Chen J, Luo W, Du Y Transl Vis Sci Technol. 2023; 12(9):12.

PMID: 37728893 PMC: 10516766. DOI: 10.1167/tvst.12.9.12.


Magnetically actuated glaucoma drainage device for regulating intraocular pressure after implantation.

Pereira I, van Mechelen R, Wyss H, Pinchuk L, Beckers H, den Toonder J Microsyst Nanoeng. 2023; 9:92.

PMID: 37484503 PMC: 10356933. DOI: 10.1038/s41378-023-00561-9.


Etiology and outcome of penetrating keratoplasty in bullous keratopathy post-cataract surgery vs post-glaucoma surgery.

Jung Y, Choi H, Kim M, Oh J PLoS One. 2023; 18(5):e0285419.

PMID: 37146064 PMC: 10162548. DOI: 10.1371/journal.pone.0285419.


The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results.

Awad-Allah M, Mousa A, Ashour D Graefes Arch Clin Exp Ophthalmol. 2023; 261(8):2343-2349.

PMID: 36869889 PMC: 10368546. DOI: 10.1007/s00417-023-06019-y.


Effect of guided Ahmed glaucoma valve implantation on corneal endothelial cells: A 2-year comparative study.

Chey J, Lee C PLoS One. 2023; 18(2):e0278340.

PMID: 36787298 PMC: 9928107. DOI: 10.1371/journal.pone.0278340.


References
1.
Assaad M, Baerveldt G, Rockwood E . Glaucoma drainage devices: pros and cons. Curr Opin Ophthalmol. 1999; 10(2):147-53. DOI: 10.1097/00055735-199904000-00012. View

2.
Sidoti P, Mosny A, Ritterband D, Seedor J . Pars plana tube insertion of glaucoma drainage implants and penetrating keratoplasty in patients with coexisting glaucoma and corneal disease. Ophthalmology. 2001; 108(6):1050-8. DOI: 10.1016/s0161-6420(01)00583-8. View

3.
Fechtner R, Singh K . Maximal glaucoma therapy. J Glaucoma. 2002; 10(5 Suppl 1):S73-5. DOI: 10.1097/00061198-200110001-00026. View

4.
Kass M, Heuer D, Higginbotham E, Johnson C, Keltner J, Miller J . The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6):701-13; discussion 829-30. DOI: 10.1001/archopht.120.6.701. View

5.
Wang J, See J, Chew P . Experience with the use of Baerveldt and Ahmed glaucoma drainage implants in an Asian population. Ophthalmology. 2004; 111(7):1383-8. DOI: 10.1016/j.ophtha.2003.11.005. View